| 000 | 01064 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513075120.0 | ||
| 264 | 0 | _c19931115 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1993.tb04210.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKolvenbach, R | |
| 245 | 0 | 0 |
_aAdenosine agonists and global cerebral ischaemia. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cAug 1993 |
||
| 300 |
_a134-5 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAdenosine _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aXanthines _xtherapeutic use |
| 700 | 1 | _aFigge, C | |
| 700 | 1 | _aGodehardt, E | |
| 700 | 1 | _aSandmann, W | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 36 _gno. 2 _gp. 134-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1993.tb04210.x _zAvailable from publisher's website |
| 999 |
_c8397855 _d8397855 |
||